Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
Head and neck squamous cell carcinoma (HNSCC) is a type of tumour with a relatively poor prognosis. In recent years, immune checkpoint inhibitors, such as CTLA-4 and PD-1/PDL-1 inhibitors, have improved the treatment status of advanced tumours. However, the emergence of drug resistance has brought d...
Saved in:
Main Authors: | Yaoting Zhang, Sultan Kadasah, Jiaheng Xie, Dongsheng Gu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Applied Bionics and Biomechanics |
Online Access: | http://dx.doi.org/10.1155/2022/3051907 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
by: Lanhua Wu, et al.
Published: (2025-01-01) -
Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
by: Changyu Zhu, et al.
Published: (2025-01-01) -
Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Vivek V. Gurudutt, et al.
Published: (2011-01-01) -
Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2025-01-01) -
An Investigation of the Prognostic Role of Genes Related to Lipid Metabolism in Head and Neck Squamous Cell Carcinoma
by: Ling Qian, et al.
Published: (2023-01-01)